Session Details
[IS01/IS02]PSJ-FIP Joint Session-2022
Part I: FIP Forum-2022
Part II: New Generations of Pharmaceutical Scientists in Asia-Pacific Regions
Sat. Mar 26, 2022 3:00 PM - 6:30 PM JST
Sat. Mar 26, 2022 6:00 AM - 9:30 AM UTC
Sat. Mar 26, 2022 6:00 AM - 9:30 AM UTC
[Room P] International Conference Rooms Bldg. 3: 3F
Organizer: Takuya Kumamoto (Grad. Sch. Biomed. Health Sci., Hiroshima Univ.), Ichiro Matsuoka (Coll. Pharm. Sci. Matsuyama Univ.)
FIP is the global body that represents pharmacy professionals including pharmacists, pharmaceutical scientists, and pharmacy educators The mission of FIP is to improve global health and well-being through the cooperative activities of BPP, BPS, and FIPEd. In 2016, powered by its close relationship with WHO, FIP adopted the Pharmaceutical Workforce Development Goals (PWDGs), a pharmacy version of the SDGs. In 2020, FIP DGs was adopted as the expansion of the PWDGs. FIP is currently working hard with its member organizations including PSJ for the achievement of the FIP DGs. For this purpose, FIP GPO (Global Pharmaceutical Observatory) has been devised as a powerful tool and database hub to indicate comprehensive aspects of the global pharmacy.
In the past Annual Meeting of the PSJ, “FIP Forum” had been held as an opportunity to advocate activities of the FIP. In this meeting, the PSJ-FIP Joint Session is organized as a new primer of our expanding collaboration between the PSJ and FIP. In the “FIP Forum”, the outline of the FIP DGs and the corresponding activities in Japan as well as in the world will be introduced. In the following “New Generations of Pharmaceutical Scientists in Asia-Pacific Regions”, with specific focuses on DG1 (Academic Capacity) and DG2 (Early Career Training), oral presentations by young pharmaceutical scientists invited from the Asia–Pacific regions will be given for the promotion of exchanges of ideas and opportunities in the pharmaceutical science activities within the regions.
In the past Annual Meeting of the PSJ, “FIP Forum” had been held as an opportunity to advocate activities of the FIP. In this meeting, the PSJ-FIP Joint Session is organized as a new primer of our expanding collaboration between the PSJ and FIP. In the “FIP Forum”, the outline of the FIP DGs and the corresponding activities in Japan as well as in the world will be introduced. In the following “New Generations of Pharmaceutical Scientists in Asia-Pacific Regions”, with specific focuses on DG1 (Academic Capacity) and DG2 (Early Career Training), oral presentations by young pharmaceutical scientists invited from the Asia–Pacific regions will be given for the promotion of exchanges of ideas and opportunities in the pharmaceutical science activities within the regions.
Introduction of PSJ-FIP Joint Session: Yoshiharu Iwabuchi (Tohoku Univ.)
Part I: FIP Forum-2022
Brief introduction of FIP Development Goals: Takuya Kumamoto (Hiroshima Univ.)
[IS01-1]What we can contribute from the viewpoint of science toward the global health
○Shigeki Sasaki1 (1. Nagasaki Intl. Univ.)
Remarks from FIP president: Dominique Jordan (International Pharmaceutical Federation (FIP))
[IS01-2]GPO and the DGs
○Catherine Duggan1 (1. International Pharmaceutical Federation (FIP))
[IS01-3]DGs and sustainable health care
○Ross McKinnon1 (1. International Pharmaceutical Federation (FIP))
[IS01-4]Application of FIP Development Goals (DGs) to evaluate the pharmacy education and training in Japan
○Shigeo Yamamura1 (1. Fac. Pharm. Sci., Josai Intl. Univ.)
Q&A and Wrap-up
Closing remarks: Hiroshi Suzuki (The Univ. of Tokyo Hospital)
(Interval)
Part II: New Generations of Pharmaceutical Scientists in Asia-Pacific Regions
Introductory remarks: Ichiro Matsuoka (Coll. Pharm. Sci., Matsuyama Univ.)
[IS02-1]Design and development of new bicyclic analogue of sulforaphane to induce nuclear factor erythroid 2-related factor
○Kit-Kay Mak1,2,3,4, Mallikarjuna Rao Pichika2,3, Mohd. Zulkefeli bin Mat Jusoh2, Ola Epemolu4, Albena T. Dinkova-Kostova5 (1. Sch. Postgrad. Stud., Intl. Med. Univ., 2. Dept. Pharm. Chem., Sch. Pharm., Intl. Med. Univ., 3. Ctr. Bioact. Mol.& Drug Deliv., Inst. Res. Dev., & Innov., Intl. Med. Univ., 4. Wellcome Ctr. Anti-infectives Res., Drug Discov. Unit, Sch. Life Sci., Univ. Dundee, 5. Jacqui Wood Cancer Ctr., Div. Cellular Med., Sch. Med., Univ. Dundee)
[IS02-2]Fabrication of cytocompatible superhydrophobic titanium dioxide-graphene coatings with antifouling properties for blood-contacting medical devices
Xun Hui Wu1, Chun-Wai Mai2, Yun Khoon Liew3, ○Yoon Yee Then2 (1. Sch. Postgrad. Stud., Intl. Med. Univ., 2. Dept. Pharm. Chem., Sch. Pharm., Intl. Med. Univ., 3. Dept. Life Sci., Sch. Pharm., Intl. Med. Univ.)
[IS02-3]Sphingosine kinase 1 as a key regulator and potential therapeutic target of breast cancer stem cells
○Ling-Wei Hii1,2, Felicia Fei-Lei Chung3, Chun Wai Mai1,4, Chee-Onn Leong1,2 (1. Ctr. Cancer & Stem Cell Res., Intl. Med. Univ., 2. Dept. Life Sci., Sch. Pharm., Intl. Med. Univ., 3. Dept. Med. Sci., Sch. Med. & Life Sci., Sunway Univ., 4. Ren Ji Hosp., Sch. Med., Shanghai Jiao Tong Univ.)
[IS02-4]Comparison of a new multidomain frailty index derived from routine health data with the hospital frailty risk score among older adults admitted to an Australian Acute Hospital
○Kenji Fujita1 (1. Fac. Med. & Health, Univ. Sydney)
[IS02-5]Harnessing the potential of non-woody biomass in hydrogel development for drug delivery to the skin
○Choon Fu Goh1, Jia Huey Poh1, Wan Ting Tan1, Li Ching Wong1, Cheu Peng Leh2 (1. Discipl. Pharm. Tech., Sch. Pharm. Sci., Sci. Univ. Malaysia, 2. Bioresource Tech., Sch. Indust. Tech., Sci. Univ. Malaysia)
[IS02-6]What is the future of international exchange from my research and extracurricular activities in my student life?
○Naofumi Tomimoto1, Reiko Sugiura1 (1. Dept. Pharm. Sci., Grad. Sch. Pharm., Kindai Univ.)
